Welcome from Dr. David Levy, President, BC Cancer Agency
I invite oncology specialists, from all disciplines, to review the substantial program, exhibits and industry symposia offered during our 2010 annual meeting in the hope that you will join us as delegates this year.
Our 2010 BC Cancer Agency Annual Cancer Conference examines Interdisciplinary Cancer Control in the 21st Century – looking at how we work together, across research and clinical specialties and platforms, to enhance and advance every facet of cancer control in British Columbia, and indeed, around the world.
Today our BC Cancer Agency scientists and genomics experts work hand-in-hand with our medical and radiation oncologists and functional imaging physicists to unravel the mysterious causes of specific cancers; continually improve the efficacy of specific preventatives, screening, diagnostics and treatments; and provide the best treatments possible for our patients. We also collaborate at every opportunity with our partners in the Provincial Health Services Authority, BC’s health regions and universities, as well as national organizations such as the Canadian Partnership Against Cancer, in sharing and consolidating our efforts to maximize health care dollars.
From November 25 through 27, over 1,000 cancer professionals will gather at the Westin Bayshore Hotel in Vancouver for the BC Cancer Agency’s premier professional development, learning and networking meeting to share recent advancements and future directions.
Those coming together include: medical and community oncologists, community and oncology nurses, nursing students, pharmacists, scientists, researchers, research students, surgeons, radiation oncologists, medical physicists, pediatric oncologists, functional imaging specialists, nutritionists, psychosocial professionals, pathologists, palliative care specialists, medical ethicists and cancer control senior leaders and administrators throughout BC and beyond.
Our annual conference is truly unique in Canada because we provide the opportunity for all specialties in the oncology field to interact, share and learn. Previous delegates, industry partners and out-of-province guests are impressed with the dynamic and diverse content and quality of the conference organization, and consistently rate it as excellent.
The conference is largely funded through greatly appreciated unrestricted educational grants from our industry partners, supplemented by the low delegate registration fees. We purposefully keep these fees low to encourage as many oncology professionals as possible to attend.
I look forward to seeing you in November at my first BC Cancer Agency Annual Cancer Conference.
All the best,
Dr. David Levy, President, BC Cancer Agency